Total Payments
$143,648
2023 Payments
$227.36
Companies
24
Transactions
301
Medicare Patients
159
Medicare Billing
$250,287
Payment Breakdown by Category
Other$98,343 (68.5%)
Travel$21,935 (15.3%)
Education$18,376 (12.8%)
Food & Beverage$4,981 (3.5%)
Gifts$14.42 (0.0%)
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | $98,343 | 51 | 68.5% |
| Travel and Lodging | $21,935 | 67 | 15.3% |
| Education | $18,376 | 32 | 12.8% |
| Food and Beverage | $4,981 | 150 | 3.5% |
| Gift | $14.42 | 1 | 0.0% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| Takeda Pharmaceuticals America, Inc. | $65,147 | 85 | $0 (2017) |
| Takeda Pharmaceuticals U.S.A., Inc. | $50,219 | 48 | $0 (2019) |
| Otsuka America Pharmaceutical, Inc. | $24,794 | 54 | $0 (2019) |
| Sunovion Pharmaceuticals Inc. | $1,137 | 44 | $0 (2021) |
| Janssen Pharmaceuticals, Inc | $489.70 | 5 | $0 (2021) |
| Allergan Inc. | $419.81 | 23 | $0 (2019) |
| Lundbeck LLC | $179.38 | 13 | $0 (2017) |
| ITI, Inc. | $173.79 | 2 | $0 (2023) |
| Neurocrine Biosciences, Inc. | $155.48 | 3 | $0 (2022) |
| Neuronetics, Inc. | $131.96 | 4 | $0 (2017) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2023 | $227.36 | 2 | Axsome Therapeutics, Inc. ($125.00) |
| 2022 | $195.70 | 2 | Neurocrine Biosciences, Inc. ($124.27) |
| 2021 | $259.33 | 5 | Janssen Pharmaceuticals, Inc ($124.99) |
| 2020 | $148.60 | 3 | Janssen Pharmaceuticals, Inc ($119.99) |
| 2019 | $12,631 | 24 | Takeda Pharmaceuticals U.S.A., Inc. ($11,649) |
| 2018 | $38,826 | 37 | Takeda Pharmaceuticals U.S.A., Inc. ($38,445) |
| 2017 | $91,361 | 228 | Takeda Pharmaceuticals America, Inc. ($65,147) |
All Payment Transactions
301 individual payment records from CMS Open Payments — Page 1 of 13
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 05/24/2023 | Axsome Therapeutics, Inc. | Auvelity (Drug) | Food and Beverage | Cash or cash equivalent | $125.00 | General |
| Category: Psychology/Psychiatric | ||||||
| 03/15/2023 | ITI, Inc. | CAPLYTA (Drug) | Food and Beverage | In-kind items and services | $102.36 | General |
| Category: PSYCHIATRY | ||||||
| 10/19/2022 | Neurocrine Biosciences, Inc. | INGREZZA (Drug) | Food and Beverage | Cash or cash equivalent | $124.27 | General |
| Category: Neuropsychiatry | ||||||
| 07/27/2022 | ITI, Inc. | CAPLYTA (Drug) | Food and Beverage | In-kind items and services | $71.43 | General |
| Category: PSYCHIATRY | ||||||
| 12/17/2021 | Sunovion Pharmaceuticals Inc. | LATUDA (Drug) | Food and Beverage | In-kind items and services | $16.43 | General |
| Category: CNS | ||||||
| 12/06/2021 | Janssen Pharmaceuticals, Inc | SPRAVATO (Drug) | Food and Beverage | In-kind items and services | $124.99 | General |
| Category: Neuroscience | ||||||
| 08/10/2021 | Sunovion Pharmaceuticals Inc. | LATUDA (Drug) | Food and Beverage | In-kind items and services | $7.56 | General |
| Category: CNS | ||||||
| 07/28/2021 | AbbVie Inc. | VRAYLAR (Drug) | Food and Beverage | In-kind items and services | $100.00 | General |
| Category: NEUROSCIENCE | ||||||
| 05/18/2021 | Sunovion Pharmaceuticals Inc. | LATUDA (Drug) | Food and Beverage | In-kind items and services | $10.35 | General |
| Category: CNS | ||||||
| 06/04/2020 | Sunovion Pharmaceuticals Inc. | LATUDA (Drug) | Food and Beverage | In-kind items and services | $28.61 | General |
| Category: CNS | ||||||
| 02/24/2020 | Janssen Pharmaceuticals, Inc | SPRAVATO (Drug) | Food and Beverage | In-kind items and services | $25.26 | General |
| Category: Neuroscience | ||||||
| 02/18/2020 | Janssen Pharmaceuticals, Inc | SPRAVATO (Drug) | Food and Beverage | In-kind items and services | $94.73 | General |
| Category: Neuroscience | ||||||
| 12/12/2019 | Sunovion Pharmaceuticals Inc. | LATUDA (Drug) | Food and Beverage | In-kind items and services | $77.44 | General |
| Category: CNS | ||||||
| 11/13/2019 | Janssen Pharmaceuticals, Inc | INVEGA SUSTENNA (Drug), INVEGA TRINZA | Food and Beverage | In-kind items and services | $119.74 | General |
| Category: Neuroscience | ||||||
| 08/21/2019 | Otsuka America Pharmaceutical, Inc. | ABILIFY MAINTENA (Drug) | Food and Beverage | In-kind items and services | $125.00 | General |
| Category: PSYCHIATRY | ||||||
| 07/17/2019 | Allergan Inc. | VRAYLAR (Drug) | Food and Beverage | In-kind items and services | $86.95 | General |
| Category: NEUROSCIENCE | ||||||
| 06/27/2019 | Sunovion Pharmaceuticals Inc. | LATUDA (Drug) | Food and Beverage | In-kind items and services | $121.36 | General |
| Category: CNS | ||||||
| 06/11/2019 | Sunovion Pharmaceuticals Inc. | LATUDA (Drug) | Food and Beverage | In-kind items and services | $113.27 | General |
| Category: CNS | ||||||
| 05/23/2019 | Janssen Pharmaceuticals, Inc | SPRAVATO (Drug) | Food and Beverage | In-kind items and services | $124.98 | General |
| Category: Neuroscience | ||||||
| 04/17/2019 | US WorldMeds, LLC | Lucemyra/Lofexidine (Drug) | Food and Beverage | In-kind items and services | $125.00 | General |
| Category: Psychiatry/Psychology | ||||||
| 03/19/2019 | Takeda Pharmaceuticals U.S.A., Inc. | Trintellix (Drug) | Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | Cash or cash equivalent | $2,040.00 | General |
| Category: Central Nervous System (CNS) | ||||||
| 03/18/2019 | Takeda Pharmaceuticals U.S.A., Inc. | Trintellix (Drug) | Food and Beverage | In-kind items and services | $40.58 | General |
| Category: Central Nervous System (CNS) | ||||||
| 03/11/2019 | Takeda Pharmaceuticals U.S.A., Inc. | Trintellix (Drug) | Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | Cash or cash equivalent | $2,520.00 | General |
| Category: Central Nervous System (CNS) | ||||||
| 03/11/2019 | Takeda Pharmaceuticals U.S.A., Inc. | Trintellix (Drug) | Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | Cash or cash equivalent | $1,320.00 | General |
| Category: Central Nervous System (CNS) | ||||||
| 03/11/2019 | Takeda Pharmaceuticals U.S.A., Inc. | Trintellix (Drug) | Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | Cash or cash equivalent | $960.00 | General |
| Category: Central Nervous System (CNS) | ||||||
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 2 | 25 | 317 | $352,850 | $44,687 |
| 2022 | 3 | 53 | 622 | $667,945 | $85,871 |
| 2021 | 3 | 41 | 358 | $337,215 | $50,025 |
| 2020 | 3 | 40 | 519 | $205,775 | $69,704 |
Total Patients
159
Total Services
1,816
Medicare Billing
$250,287
Procedure Codes
11
All Medicare Procedures & Services
11 procedure records from CMS Medicare Utilization
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 90868 | Treatment using magnetic field to stimulate nerve cells in brain, subsequent delivery and management | Office | 2023 | 14 | 305 | $332,450 | $42,925 | 12.9% |
| 90867 | Treatment using magnetic field to stimulate nerve cells in brain, initial delivery and management | Office | 2023 | 11 | 12 | $20,400 | $1,762 | 8.6% |
| 90868 | Treatment using magnetic field to stimulate nerve cells in brain, subsequent delivery and management | Office | 2022 | 20 | 578 | $630,020 | $81,828 | 13.0% |
| 90867 | Treatment using magnetic field to stimulate nerve cells in brain, initial delivery and management | Office | 2022 | 17 | 19 | $32,300 | $2,617 | 8.1% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2022 | 16 | 25 | $5,625 | $1,426 | 25.4% |
| 90868 | Transcranial magnetic stimulation treatment (stimulates nerve cells in brain to improve symptoms of depression), subsequent delivery and management, per session | Office | 2021 | 17 | 328 | $314,740 | $47,146 | 15.0% |
| 90867 | Transcranial magnetic stimulation treatment (stimulates nerve cells in brain to improve symptoms of depression), initial delivery and management | Office | 2021 | 13 | 13 | $18,650 | $1,816 | 9.7% |
| 99213 | Established patient outpatient visit, total time 20-29 minutes | Office | 2021 | 11 | 17 | $3,825 | $1,063 | 27.8% |
| 90868 | Transcranial magnetic stimulation treatment (stimulates nerve cells in brain to improve symptoms of depression), per session | Office | 2020 | 13 | 477 | $190,800 | $66,051 | 34.6% |
| 90867 | Transcranial magnetic stimulation treatment (stimulates nerve cells in brain to improve symptoms of depression) | Office | 2020 | 13 | 17 | $9,350 | $2,471 | 26.4% |
| 99213 | Established patient office or other outpatient visit, typically 15 minutes | Office | 2020 | 14 | 25 | $5,625 | $1,182 | 21.0% |
About Dr. Parish Mckinney, MD
Dr. Parish Mckinney, MD is a Psychiatry healthcare provider based in Greensboro, North Carolina. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 10/17/2007. The National Provider Identifier (NPI) number assigned to this provider is 1437348398.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. Parish Mckinney, MD has received a total of $143,648 in payments from pharmaceutical and medical device companies, with $227.36 received in 2023. These payments were reported across 301 transactions from 24 companies. The most common payment nature is "Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program" ($98,343).
As a Medicare-enrolled provider, Mckinney has provided services to 159 Medicare beneficiaries, totaling 1,816 services with total Medicare billing of $250,287. Data is available for 4 years (2020–2023), covering 11 distinct procedure/service records.
Ad
Practice Information
- Specialty Psychiatry
- Location Greensboro, NC
- Active Since 10/17/2007
- Last Updated 10/17/2007
- Taxonomy Code 2084P0800X
- Entity Type Individual
- Practice Solo Practitioner
- NPI Number 1437348398
Products in Payments
- Trintellix (Drug) $96,884
- REXULTI (Drug) $24,722
- LATUDA (Drug) $1,137
- VRAYLAR (Drug) $507.80
- SPRAVATO (Drug) $369.96
- TRINTELLIX (Drug) $189.97
- CAPLYTA (Drug) $173.79
- ABILIFY MAINTENA (Drug) $172.31
- INGREZZA (Drug) $155.48
- NeuroStar TMS Therapy (Device) $131.96
- CONTRAVE (Drug) $126.75
- Auvelity (Drug) $125.00
- Lucemyra/Lofexidine (Drug) $125.00
- Aristada 441 mg (Drug) $120.00
- INVEGA SUSTENNA (Drug) $119.74
- Adzenys XR-ODT (Drug) $32.20
- Fanapt (Drug) $28.29
- OXTELLAR XR (Drug) $28.19
- BELSOMRA (Drug) $24.79
- Evekeo (Drug) $21.90
Explore
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.
Psychiatry Doctors in Greensboro
Dr. Gerald Plovsky, Md, MD
Psychiatry — Payments: $36,312
Psychiatry $36,312
Dr. Kenneth Headen, Md, MD
Psychiatry — Payments: $14,366
Psychiatry $14,366
Dr. Rupinder Kaur, M.d, M.D
Psychiatry — Payments: $13,042
Psychiatry $13,042
Carey Cottle, Md, MD
Psychiatry — Payments: $10,156
Psychiatry $10,156
Dr. Scott Cunningham, Md, MD
Psychiatry — Payments: $5,932
Psychiatry $5,932
Dr. Archana Kumar, Md, MD
Psychiatry — Payments: $3,814
Psychiatry $3,814